Inhibitors in patients with haemophilia [[electronic resource] /] / edited by E.C. Rodriguez-Merchan, C.A. Lee |
Pubbl/distr/stampa | Osney Mead, Oxford ; ; Malden, MA, : Blackwell Science, c2002 |
Descrizione fisica | 1 online resource (230 p.) |
Disciplina | 616.1/572 |
Altri autori (Persone) |
Rodriguez-MerchanE. C
LeeChristine A |
Soggetto topico |
Hemophilia - Pathophysiology
Hemophilia - Treatment - Complications Hemophilia - Immunological aspects |
ISBN |
1-281-32099-4
9786611320997 0-470-75726-4 0-470-75724-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inhibitors in Patients with Haemophilia; Contents; Contributors; Preface; Part 1: Haematology; 1 Natural history of inhibitors in severe haemophilia A and B: incidence and prevalence; 2 Characterization of inhibitors in congenital haemophilia; 3 Incidence and prevalence of inhibitors and type of blood product in haemophilia A; 4 Genetic basis of inhibitor development in severe haemophilia A and B; Part 2: Management of treatment; 5 Methods: plasmapheresis and protein A immunoadsorption; 6 Venous access in children with inhibitors; Part 3: Immune tolerance
7 Immune tolerance: high-dose regimen8 Immune tolerance: low-dose regimen; 9 Immune tolerance and choice of concentrates; 10 Immune tolerance: The North American Immune Tolerance Registry; Part 4: Medical management of bleeding episodes; 11 The treatment of bleeding episodes in children; 12 General medical management of bleeding episodes: haemarthroses, muscle haematomas, mucocutaneous bleeding and haematuria; 13 Life- and limb-threatening episodes and intracranial bleeds; Part 5: Inhibitors in haemophilia B, inhibitors in mild and moderate haemophilia A and acquired inhibitors to FVIII 14 Factor IX inhibitors and anaphylaxis15 Inhibitors in mild and moderate haemophilia A; 16 Acquired inhibitors to factor VIII; Part 6: Musculoskeletal issues; 17 Pathogenesis of musculoskeletal complications of haemophilia; 18 Orthopaedic management of haemarthroses; 19 Chemical synoviorthesis; 20 Radiosynoviorthesis in patients with haemophilia and inhibitors; 21 Musculoskeletal magnetic resonance imaging; 22 Treatment of iliopsoas haematomas and compartment syndromes in patients with haemophilia who have a circulating antibody 23 A rational approach to the treatment of haemophilic blood cyst (pseudotumour) in patients with inhibitors24 Haemophilia patients with inhibitors: a rheumatologist's point of view; 25 Rehabilitation of patients with haemophilia and inhibitors; 26 Physiotherapy in the management of patients with inhibitors; 27 Elective orthopaedic surgery in haemophilia patients with high-responding inhibitors; Part 7: General surgery; 28 General and emergency surgery in patients with high-responding inhibitors; 29 Dental extraction in patients with haemophilia and inhibitors; Part 8: Psychosocial issues 30 Psychosocial impact of inhibitors on haemophilia patients' quality of lifePart 9: General strategy for management of inhibitor patients; 31 General strategy for management of inhibitor patients (summary); 32 Immunoadsorption with anti-immunoglobulin antibodies using Ig-TheraSorb columns; 33 Standard, high and mega bolus doses of rVIIa or recombinant VIIa: comparison of three different treatment regimens; Index |
Record Nr. | UNINA-9910145421403321 |
Osney Mead, Oxford ; ; Malden, MA, : Blackwell Science, c2002 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Inhibitors in patients with haemophilia [[electronic resource] /] / edited by E.C. Rodriguez-Merchan, C.A. Lee |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Osney Mead, Oxford ; ; Malden, MA, : Blackwell Science, c2002 |
Descrizione fisica | 1 online resource (230 p.) |
Disciplina | 616.1/572 |
Altri autori (Persone) |
Rodriguez-MerchanE. C
LeeChristine A |
Soggetto topico |
Hemophilia - Pathophysiology
Hemophilia - Treatment - Complications Hemophilia - Immunological aspects |
ISBN |
1-281-32099-4
9786611320997 0-470-75726-4 0-470-75724-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inhibitors in Patients with Haemophilia; Contents; Contributors; Preface; Part 1: Haematology; 1 Natural history of inhibitors in severe haemophilia A and B: incidence and prevalence; 2 Characterization of inhibitors in congenital haemophilia; 3 Incidence and prevalence of inhibitors and type of blood product in haemophilia A; 4 Genetic basis of inhibitor development in severe haemophilia A and B; Part 2: Management of treatment; 5 Methods: plasmapheresis and protein A immunoadsorption; 6 Venous access in children with inhibitors; Part 3: Immune tolerance
7 Immune tolerance: high-dose regimen8 Immune tolerance: low-dose regimen; 9 Immune tolerance and choice of concentrates; 10 Immune tolerance: The North American Immune Tolerance Registry; Part 4: Medical management of bleeding episodes; 11 The treatment of bleeding episodes in children; 12 General medical management of bleeding episodes: haemarthroses, muscle haematomas, mucocutaneous bleeding and haematuria; 13 Life- and limb-threatening episodes and intracranial bleeds; Part 5: Inhibitors in haemophilia B, inhibitors in mild and moderate haemophilia A and acquired inhibitors to FVIII 14 Factor IX inhibitors and anaphylaxis15 Inhibitors in mild and moderate haemophilia A; 16 Acquired inhibitors to factor VIII; Part 6: Musculoskeletal issues; 17 Pathogenesis of musculoskeletal complications of haemophilia; 18 Orthopaedic management of haemarthroses; 19 Chemical synoviorthesis; 20 Radiosynoviorthesis in patients with haemophilia and inhibitors; 21 Musculoskeletal magnetic resonance imaging; 22 Treatment of iliopsoas haematomas and compartment syndromes in patients with haemophilia who have a circulating antibody 23 A rational approach to the treatment of haemophilic blood cyst (pseudotumour) in patients with inhibitors24 Haemophilia patients with inhibitors: a rheumatologist's point of view; 25 Rehabilitation of patients with haemophilia and inhibitors; 26 Physiotherapy in the management of patients with inhibitors; 27 Elective orthopaedic surgery in haemophilia patients with high-responding inhibitors; Part 7: General surgery; 28 General and emergency surgery in patients with high-responding inhibitors; 29 Dental extraction in patients with haemophilia and inhibitors; Part 8: Psychosocial issues 30 Psychosocial impact of inhibitors on haemophilia patients' quality of lifePart 9: General strategy for management of inhibitor patients; 31 General strategy for management of inhibitor patients (summary); 32 Immunoadsorption with anti-immunoglobulin antibodies using Ig-TheraSorb columns; 33 Standard, high and mega bolus doses of rVIIa or recombinant VIIa: comparison of three different treatment regimens; Index |
Record Nr. | UNISA-996218293603316 |
Osney Mead, Oxford ; ; Malden, MA, : Blackwell Science, c2002 | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Inhibitors in patients with haemophilia / / edited by E.C. Rodriguez-Merchan, C.A. Lee |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Osney Mead, Oxford ; ; Malden, MA, : Blackwell Science, c2002 |
Descrizione fisica | 1 online resource (230 p.) |
Disciplina | 616.1/572 |
Altri autori (Persone) |
Rodriguez-MerchanE. C
LeeChristine A |
Soggetto topico |
Hemophilia - Pathophysiology
Hemophilia - Treatment - Complications Hemophilia - Immunological aspects |
ISBN |
1-281-32099-4
9786611320997 0-470-75726-4 0-470-75724-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inhibitors in Patients with Haemophilia; Contents; Contributors; Preface; Part 1: Haematology; 1 Natural history of inhibitors in severe haemophilia A and B: incidence and prevalence; 2 Characterization of inhibitors in congenital haemophilia; 3 Incidence and prevalence of inhibitors and type of blood product in haemophilia A; 4 Genetic basis of inhibitor development in severe haemophilia A and B; Part 2: Management of treatment; 5 Methods: plasmapheresis and protein A immunoadsorption; 6 Venous access in children with inhibitors; Part 3: Immune tolerance
7 Immune tolerance: high-dose regimen8 Immune tolerance: low-dose regimen; 9 Immune tolerance and choice of concentrates; 10 Immune tolerance: The North American Immune Tolerance Registry; Part 4: Medical management of bleeding episodes; 11 The treatment of bleeding episodes in children; 12 General medical management of bleeding episodes: haemarthroses, muscle haematomas, mucocutaneous bleeding and haematuria; 13 Life- and limb-threatening episodes and intracranial bleeds; Part 5: Inhibitors in haemophilia B, inhibitors in mild and moderate haemophilia A and acquired inhibitors to FVIII 14 Factor IX inhibitors and anaphylaxis15 Inhibitors in mild and moderate haemophilia A; 16 Acquired inhibitors to factor VIII; Part 6: Musculoskeletal issues; 17 Pathogenesis of musculoskeletal complications of haemophilia; 18 Orthopaedic management of haemarthroses; 19 Chemical synoviorthesis; 20 Radiosynoviorthesis in patients with haemophilia and inhibitors; 21 Musculoskeletal magnetic resonance imaging; 22 Treatment of iliopsoas haematomas and compartment syndromes in patients with haemophilia who have a circulating antibody 23 A rational approach to the treatment of haemophilic blood cyst (pseudotumour) in patients with inhibitors24 Haemophilia patients with inhibitors: a rheumatologist's point of view; 25 Rehabilitation of patients with haemophilia and inhibitors; 26 Physiotherapy in the management of patients with inhibitors; 27 Elective orthopaedic surgery in haemophilia patients with high-responding inhibitors; Part 7: General surgery; 28 General and emergency surgery in patients with high-responding inhibitors; 29 Dental extraction in patients with haemophilia and inhibitors; Part 8: Psychosocial issues 30 Psychosocial impact of inhibitors on haemophilia patients' quality of lifePart 9: General strategy for management of inhibitor patients; 31 General strategy for management of inhibitor patients (summary); 32 Immunoadsorption with anti-immunoglobulin antibodies using Ig-TheraSorb columns; 33 Standard, high and mega bolus doses of rVIIa or recombinant VIIa: comparison of three different treatment regimens; Index |
Record Nr. | UNINA-9910810241003321 |
Osney Mead, Oxford ; ; Malden, MA, : Blackwell Science, c2002 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|